Before using an anti-tTG antibody, antigliadin antibody, and EMA were the serologic tests considered for screening and as diagnostic tools for CD. EMA has very high specificity but low sensitivity, which makes it an unreliable tool in clinical practice for screening patients with CD [16]. This evidence concerns the gene TGM2 and Cowden disease.